| APTOSE BIOSCIENCES |
| Kanada |
| Gesundheit |
| CA03835T4081 / A40YEP |
| LTI0 (Frankfurt) |
| FRA:LTI0, ETR:LTI0, LTI0:GR |
| - |
| https://www.aptose.com/ |
|
Aptose Biosciences Inc. is a clinical-stage biotechnology company focused on developing precision medicines to address unmet medical needs in oncology, primarily targeting hematological cancers. The company's pipeline features small molecule therapeu..
>Volltext.. |
| 3.8 Mio. EUR |
| 18.59 Mio. EUR |
| - |
| -16.59 Mio. EUR |
| -16.78 Mio. EUR |
| -7.11 EUR |
| 16.46 Mio. EUR |
| 1.42 Mio. EUR |
| -21.11 Mio. EUR |
| 0.23 |
| - |
| 48.93% |
| - |
| - |
| - |
| - |
| APTOSE BIOSCIENCES, APTOSE BIO |
| 05.04.26 |
|
||||
|